Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy

Area of Science:

• Interventional Cardiology
• Cardiovascular Research

Background:

• Left main and bifurcation lesions are key features of complex percutaneous coronary intervention (PCI).
• Stenting these lesions, particularly at the distal left main bifurcation, presents significant technical challenges.
• These complex PCI cases are linked to a higher risk of ischemic events.

Purpose of the Study:

• To review current understanding and challenges in left main and bifurcation PCI.
• To explore the evolving landscape of antithrombotic therapy for high-risk PCI patients.
• To highlight the need for consensus on optimal PCI strategies and antithrombotic regimens.

Main Methods:

• Review of recent evidence and clinical investigations.
• Analysis of antithrombotic therapy options, including prolonged dual antiplatelet therapy and potent P2Y12 inhibitors.
• Consideration of factors influencing treatment decisions: clinical presentation, bleeding risk, ischemic risk, and stenting strategy.

Main Results:

• Left main and bifurcation PCI represent a substantial portion of complex PCI procedures.
• There is ongoing investigation into prolonged dual antiplatelet therapy and potent P2Y12 inhibitors for this patient subset.
• Current decision-making for antithrombotic therapy is multifactorial, balancing risks and patient characteristics.

Conclusions:

• Left main and bifurcation PCI are critical areas within complex PCI.
• Optimal antithrombotic strategies to mitigate thrombotic risk remain an active area of research.
• Personalized treatment approaches are essential, considering individual patient risk profiles and procedural complexity.